{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:42Z","timestamp":1793387262395,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis B virus (HBV) and\/or hepatitis C virus (HCV). Knowledge of the changes in the incidence of viral hepatitis-associated HCC over time and the factors responsible for such changes is key in informing policies for the prevention of viral hepatitis-associated HCC in Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The study aimed to systematically summarize the changes in the prevalence of viral hepatitis among HCC patients and the overall effect of the prevalence of viral hepatitis on the incidence of HCC over the past four decades in Africa (1980\u20132019).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A literature search was conducted in MEDLINE (PubMed), Google Scholar, Science Direct, Scopus, Web of Science, and African wide web for articles published on viral hepatitis-associated HCC in Africa from 1980 to 2019. The abstracts of the articles were screened for eligibility and those meeting the inclusion criteria were retrieved and reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 272 studies were included in the analysis. Viral hepatitis-related HCC incidence changed by 1.17% (95% confidence interval (CI): 0.63\u20131.71, <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>), 0.82% (95% CI: 0.45\u20131.18, <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>), and 3.34% (95% CI: 2.44\u20134.25, <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>) for every 1% change in the prevalence of HBV, HCV, and hepatitis D virus (HDV) respectively, per decade. The incidence of HBV-related HCC decreased by \u2212\u20090.50% (95% CI: \u2212\u20090.74 \u2013 \u2212\u20090.25, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) over the last 40\u2009years, while HCV-related HCC increased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, the incidence of viral hepatitis-associated HCC has not declined, mainly due to no decline in the prevalence of HCV, HDV, and the high number of chronic hepatitis B carriers on the African continent. There is an urgent need for the allocation of resources for the implementation of treatment and preventive programs for HBV, HCV, HDV, and HCC in Africa.<\/jats:p>\n                <jats:p>This systematic review is registered with PROSPERO\u00ae, number CRD42020169723.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08426-y","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T04:03:22Z","timestamp":1624075402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review"],"prefix":"10.1186","volume":"21","author":[{"given":"Ottovon Bismark","family":"Dakurah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Raissa Tchuem","family":"Tamandjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moleen","family":"Zunza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongai Gibson","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"issue":"8b","key":"8426_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7196\/SAMJ.2018.v108i8b.13499","volume":"108","author":"K Zakharia","year":"2018","unstructured":"Zakharia K, Luther CA, Alsabbak H, Roberts LR. Hepatocellular carcinoma: epidemiology, pathogenesis, and surveillance - implications for sub-Saharan Africa. S Afr Med J. 2018;108(8b):35\u201340. https:\/\/doi.org\/10.7196\/SAMJ.2018.v108i8b.13499.","journal-title":"S Afr Med J"},{"issue":"2","key":"8426_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0039-3399566","volume":"40","author":"E Okeke","year":"2019","unstructured":"Okeke E, Davwar PM, Roberts L, Sartorius K, Spearman W, Mali A, et al. Epidemiology of liver Cancer in Africa: current and future trends. Semin Liver Dis. 2019;40(2):111\u201323. https:\/\/doi.org\/10.1055\/s-0039-3399566.","journal-title":"Semin Liver Dis"},{"issue":"12","key":"8426_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/JAMAOncol.2017.3055","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683\u201391. https:\/\/doi.org\/10.1001\/JAMAOncol.2017.3055.","journal-title":"JAMA Oncol"},{"issue":"3","key":"8426_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canep.2015.04.006","volume":"39","author":"K Sartorius","year":"2015","unstructured":"Sartorius K, Sartorius B, Aldous C, Govender PS, Madiba TE. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol Elsevier Ltd. 2015;39(3):284\u201390. https:\/\/doi.org\/10.1016\/j.canep.2015.04.006.","journal-title":"Cancer Epidemiol Elsevier Ltd"},{"issue":"6","key":"8426_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jamal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"A Cancer J Clin"},{"issue":"2","key":"8426_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology, and surveillance for hepatocellular carcinoma: new trends, journal of hepatology. Eur Assoc Study Liver. 2020;72(2):250\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.025.","journal-title":"Eur Assoc Study Liver"},{"issue":"12","key":"8426_CR7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917. https:\/\/doi.org\/10.1002\/ijc.25516.","journal-title":"Int J Cancer"},{"key":"8426_CR8","unstructured":"IARC. Latest global cancer data. IARC Global Cancer Observatory, In: 2018 Sept 12 []. Available from: http:\/\/gco.iarc.fr\/."},{"issue":"3","key":"8426_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jhep.2016.10.013","volume":"66","author":"M Lemoine","year":"2017","unstructured":"Lemoine M, Thursz MR. Battlefield against hepatitis B infection and HCC in Africa. J Hepatol. 2017;66(3):645\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2016.10.013.","journal-title":"J Hepatol"},{"issue":"3","key":"8426_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/cej.0000000000000428","volume":"27","author":"A Baecker","year":"2018","unstructured":"Baecker A, Xing L, Carlo LV, Zuo-Feng Z. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27(3):205\u201312. https:\/\/doi.org\/10.1097\/cej.0000000000000428.","journal-title":"Eur J Cancer Prev"},{"key":"8426_CR11","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2017. IHME. 2018; 5\u201323. Available at: http:\/\/www.healthdata.org\/sites\/default\/files\/files\/policy. [Accessed 5 June 2019]."},{"key":"8426_CR12","doi-asserted-by":"publisher","unstructured":"Lin L, Yan L, Liu Y, Qu C, Ni J, Li H. The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017. Liver Cancer. 2020;9(5):563\u201382. https:\/\/doi.org\/10.1159\/000508568.","DOI":"10.1159\/000508568"},{"issue":"6","key":"8426_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma\u2019. Gastroenterology. 2012;142(6):1264\u201373. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061.","journal-title":"Gastroenterology."},{"issue":"2019","key":"8426_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3332\/ecancer.2019.950","volume":"13","author":"P Ndom","year":"2019","unstructured":"Ndom P. Cancer prevention in Africa: liver cancer. E Cancer Med Sci. 2019;13(2019):1\u20138. https:\/\/doi.org\/10.3332\/ecancer.2019.950.","journal-title":"E Cancer Med Sci"},{"issue":"2","key":"8426_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1665-2681(19)31354-7","volume":"12","author":"MC Kew","year":"2013","unstructured":"Kew MC. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol. 2013;12(2):173\u201382. https:\/\/doi.org\/10.1016\/S1665-2681(19)31354-7.","journal-title":"Ann Hepatol"},{"key":"8426_CR16","doi-asserted-by":"publisher","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X.","DOI":"10.1016\/S0140-6736(15)61412-X"},{"key":"8426_CR17","unstructured":"WHO: Global hepatitis report, In: 2017. Available at https:\/\/apps.who.int\/iris\/handle\/10665\/255016 []."},{"issue":"13","key":"8426_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","volume":"6","author":"M Jefferies","year":"2018","unstructured":"Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on the global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018;6(13):589\u201399. https:\/\/doi.org\/10.12998\/wjcc.v6.i13.589.","journal-title":"World J Clin Cases"},{"issue":"1","key":"8426_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40249-019-0526-8","volume":"8","author":"JJ Bigna","year":"2019","unstructured":"Bigna JJ, Kenne AM, Hamroun A, Ndangang MS, Foka AJ, Tounoung DN, et al. Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis. Infect Dis Poverty. 2019;8(1):2\u201312. https:\/\/doi.org\/10.1186\/s40249-019-0526-8.","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"8426_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7196\/samj.2020.V110i2.14208","volume":"110","author":"R Nordien","year":"2020","unstructured":"Nordien R, Sonderup MW, Spearman CW. A decade of hepatitis C at the University of Cape Town\/Groote Schuur hospital liver clinic, South Africa, in the pre-direct-acting antivirals era. S Afr Med J. 2020;110(2):106\u201311. https:\/\/doi.org\/10.7196\/samj.2020.V110i2.14208.","journal-title":"S Afr Med J"},{"issue":"5","key":"8426_CR21","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1128\/JCM.02297-13","volume":"52","author":"IE Andernach","year":"2014","unstructured":"Andernach IE, Leiss LV, Tarnagda ZS, Tahita MC, Otegbayo JA, Forbi JC, et al. Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol. 2014;52(5):1629\u201336. https:\/\/doi.org\/10.1128\/JCM.02297-13.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8426_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jiph.2018.12.001","volume":"12","author":"NA Makhlouf","year":"2019","unstructured":"Makhlouf NA, Morsy KH, Mahmoud AA. Hepatitis D virus infection among hepatitis B virus surface antigen-positive individuals in upper Egypt: prevalence and clinical features. Journal of Infection, and Public Health. 2019;12(3):350\u20136. https:\/\/doi.org\/10.1016\/j.jiph.2018.12.001.","journal-title":"Journal of Infection, and Public Health"},{"issue":"10","key":"8426_CR23","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1016\/S2214-109X(17)30298-X","volume":"5","author":"AJ Stockdale","year":"2017","unstructured":"Stockdale AJ, Chaponda M, Beloukas A, Philipps RO, Mathew PC, Papadimitropoulos A, et al. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(10):e992\u2013e1003. https:\/\/doi.org\/10.1016\/S2214-109X(17)30298-X.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"8426_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12879-016-1992-2","volume":"16","author":"MA Amougou","year":"2016","unstructured":"Amougou MA, Dominique NN, Moundipa PF, Pineal P, Njouom R. A prominent role of hepatitis D virus in liver cancers documented in Central Africa. BMC Infect Dis. 2016;16(1):2\u20138. https:\/\/doi.org\/10.1186\/s12879-016-1992-2.","journal-title":"BMC Infect Dis"},{"key":"8426_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1155\/2018\/9312650","volume":"2018","author":"MA Daw","year":"2018","unstructured":"Daw MA, Daw AM, Sifennasr NE, Draha AM, Daw AM, Daw AM, et al. The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis. Sci World J. 2018;2018:2\u201311. https:\/\/doi.org\/10.1155\/2018\/9312650.","journal-title":"Sci World J"},{"issue":"8256","key":"8426_CR26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0140-6736(81)90585-7","volume":"2","author":"RP Beasley","year":"1981","unstructured":"Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2(8256):1129\u201333. https:\/\/doi.org\/10.1016\/s0140-6736(81)90585-7.","journal-title":"Lancet."},{"issue":"3","key":"8426_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5009\/gnl15257","volume":"10","author":"RX Zhu","year":"2016","unstructured":"Zhu RX, Seto W, Lai C, Yuen M. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 2016;10(3):332\u20139. https:\/\/doi.org\/10.5009\/gnl15257.","journal-title":"Gut Liver"},{"issue":"12","key":"8426_CR28","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116.","journal-title":"Vaccine"},{"key":"8426_CR29","doi-asserted-by":"crossref","unstructured":"Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J, 2017;27(Supp 3):17. Doi: 10.11604\/pamj.supp.2017.27.3.11981.","DOI":"10.11604\/pamj.supp.2017.27.3.11981"},{"issue":"1","key":"8426_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","volume":"66","author":"JJ Ott","year":"2017","unstructured":"Ott JJ, Horn J, Kraus G, Mikolajczyk RF. Time trends of chronic HBV infection over prior decades \u2013 a global analysis. J Hepatol. 2017;66(1):48\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.013.","journal-title":"J Hepatol"},{"key":"8426_CR31","doi-asserted-by":"crossref","unstructured":"Tamandjou CR, Maponga TG, Chotun N, Preiser W, Anderson MI. Is hepatitis B birth dose vaccine needed in Africa? Pan Afr Med J. 2017; 27(Supp 3):18. DOI: 10.11604\/pamj.supp.2017.27.3.11546.","DOI":"10.11604\/pamj.supp.2017.27.3.11546"},{"issue":"3","key":"8426_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.gastro.2016.05.048","volume":"151","author":"M-H Chang","year":"2016","unstructured":"Chang M-H, You S-L, Chen C-J, Liu C-J, Lai M-W, Wu T-C, et al. Long-term effects of hepatitis B immunization of infants in preventing liver Cancer. Gastroenterology. 2016;151(3):472\u201380. https:\/\/doi.org\/10.1053\/j.gastro.2016.05.048.","journal-title":"Gastroenterology."},{"key":"8426_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","volume":"4","author":"GS Cooke","year":"2019","unstructured":"Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, et al. Accelerating the elimination of viral hepatitis : a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135\u201384. https:\/\/doi.org\/10.1016\/S2468-1253(18)30270-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"8426_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-2389-7","volume":"15","author":"P Adoba","year":"2015","unstructured":"Adoba P, Boadu SK, Agbodzakey H, Somuah D, Ephraim RKD, Odame EA. High prevalence of hepatitis B and poor knowledge on hepatitis B and C viral infections among barbers: a cross-sectional study of the Obuasi municipality, Ghana. BMC Public Health. 2015;15(1):1\u20137. https:\/\/doi.org\/10.1186\/s12889-015-2389-7.","journal-title":"BMC Public Health"},{"issue":"1","key":"8426_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-5672-6","volume":"18","author":"NY Sultan","year":"2018","unstructured":"Sultan NY, Yacoobmayet A, Alaqeel SA, Al-Omar HA. Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians. BMC Public Health. 2018;18(1):1\u20138. https:\/\/doi.org\/10.1186\/s12889-018-5672-6.","journal-title":"BMC Public Health"},{"issue":"4","key":"8426_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jceh.2018.01.001","volume":"8","author":"HN Luma","year":"2018","unstructured":"Luma HN, Eloumou SAFB, Noah DN, Eyenga BA, Nko'Ayissi G, Taku TS, et al. Hepatitis C continuum of Care in a Treatment Center in sub-Saharan Africa, journal of clinical and experimental hepatology. Elsevier BV. 2018;8(4):335\u201341. https:\/\/doi.org\/10.1016\/j.jceh.2018.01.001.","journal-title":"Elsevier BV"},{"key":"8426_CR37","unstructured":"WHO: Hepatitis D, In: 2019. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d []."},{"issue":"2","key":"8426_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jhep.2014.10.008","volume":"62","author":"M Lemoine","year":"2015","unstructured":"Lemoine M, Eholi\u00e9 S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, journal of hepatology. Eur Assoc Study Liver. 2015;62(2):469\u201376. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.008.","journal-title":"Eur Assoc Study Liver"},{"issue":"1","key":"8426_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4254\/wjh.v3.i1.24","volume":"3","author":"O Bahri","year":"2011","unstructured":"Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, El Feydi AE, Mestiri H, et al. First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol. 2011;3(1):24\u201330. https:\/\/doi.org\/10.4254\/wjh.v3.i1.24.","journal-title":"World J Hepatol"},{"issue":"1","key":"8426_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/hep.20027","volume":"39","author":"GD Kirk","year":"2004","unstructured":"Kirk GD, Lesi OA, Mandy M, Akano AO, Sam O, Goedert JJ, et al. The Gambia liver Cancer study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology. 2004;39(1):211\u20139. https:\/\/doi.org\/10.1002\/hep.20027.","journal-title":"Hepatology"},{"issue":"1","key":"8426_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01372-2","volume":"20","author":"TG Maponga","year":"2020","unstructured":"Maponga TG, Richard HG, Hannali V, Barbara R, Burmeister S, Vernon M, et al. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterol. 2020;20(1):1\u20139. https:\/\/doi.org\/10.1186\/s12876-020-01372-2.","journal-title":"BMC Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08426-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08426-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08426-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T04:03:41Z","timestamp":1624075421000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08426-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8426"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08426-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and informed consent was waived by the Health Research Ethics Committee (HREC 2) at the Faculty of Medicine and Health Science, Stellenbosch University (HREC reference number: X19\/10\/041).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"715"}}